Location History:
- Leganes-Madrid, ES (2011)
- Madrid, ES (2011)
- Tres Cantos, ES (2013)
Company Filing History:
2 out of 4 
1 out of 2 
1 out of 8 Years Active: 2011-2013
Title: Esther Garcia Palomero: Innovator in Neurodegenerative Disease Treatment
Introduction
Esther Garcia Palomero is a prominent inventor based in Leganes-Madrid, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative and hematological diseases. With a total of 3 patents to her name, her work is paving the way for new therapeutic approaches.
Latest Patents
One of her latest patents involves the development of [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or hematological diseases. This invention relates to a new family of [1,10]-phenanthroline derivatives, which are useful for treating or preventing neurodegenerative or hematological conditions. The patent also covers their use as a medicament and includes a pharmaceutical composition comprising these compounds.
Another significant patent focuses on the use of Collismycin and its derivatives as inhibitors of oxidative stress in cells. This invention is particularly relevant for the preparation of medicaments aimed at treating oxidative stress-induced diseases, including neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease.
Career Highlights
Esther has worked with notable companies in the pharmaceutical sector, including Noscira, S.A. and Neuropharma, S.A. Her experience in these organizations has contributed to her expertise in developing innovative treatments for complex medical conditions.
Collaborations
Throughout her career, Esther has collaborated with talented professionals, including Ana Martinez Gil and Paola Usan Egea. These partnerships have enhanced her research and development efforts, leading to impactful innovations in her field.
Conclusion
Esther Garcia Palomero is a trailblazer in the realm of medical inventions, particularly in addressing neurodegenerative diseases. Her patents reflect her commitment to advancing healthcare solutions and improving patient outcomes.